Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Tatiana Kutateladze to Drug Design

This is a "connection" page, showing publications Tatiana Kutateladze has written about Drug Design.

 
Connection Strength
 
 
 
1.053
 
  1. Vann KR, Pal D, Morales GA, Burgoyne AM, Durden DL, Kutateladze TG. Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets. Sci Rep. 2020 07 21; 10(1):12027.
    View in: PubMed
    Score: 0.638
  2. Allen HF, Daze KD, Shimbo T, Lai A, Musselman CA, Sims JK, Wade PA, Hof F, Kutateladze TG. Inhibition of histone binding by supramolecular hosts. Biochem J. 2014 May 01; 459(3):505-12.
    View in: PubMed
    Score: 0.415
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)